Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-04

Clinical Trial Update: Glistenings and PCO Evaluation for the Envista MX60

View source ↗

Summary

This completed trial evaluated glistenings and posterior capsule opacification in the Envista MX60 intraocular lens used in cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Envista MX60 intraocular lens

Snippet

Sponsor: Democritus University of Thrace | Conditions: Cataract | Status: COMPLETED